Targeting TLR4‐Depended NLRP3 Inflammasome: Sulforaphane's Mechanism in Suppressing Neuroinflammation and Seizures in Epileptic Mice
Molecular Nutrition & Food Research · 2026-06 · 70 (11)
DOI: 10.1002/mnfr.70510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 01.06.2026. Verfasst von Guoli Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ningxia Key Laboratory of Craniocerebral Diseases, Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Isothiocyanates, Toll-Like Receptor 4, Inflammasomes. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Ningxia, Natural Science Foundation of Ningxia Province.
Abstract (Originalsprache)
This study aimed to elucidate the role of the TLR4 pathway in the antiepileptic effects of sulforaphane (SFN). C57BL/6 mice were randomized into control, SFN, epilepsy (EP), and SFN intervention groups. SFN was administered for 7 days (25 mg/kg/day, oral gavage) to the intervention and SFN groups before epilepsy was induced. Epilepsy was induced in the EP and intervention groups using a lithium chloride–pilocarpine protocol. Behavioral and electroencephalogram (EEG) data were collected. Hippocampal tissue was examined for inflammatory markers and histopathological changes, and protein expression in the TLR4/NF‑κB/NLRP3 pathway was assessed by western blot. The involvement of TLR4 was further validated through intraperitoneal administration of the selective inhibitor TAK‑242 (3.0 mg/kg). SFN pretreatment significantly ameliorated seizure severity, mortality, pathologically elevated EEG delta wave frequency, hippocampal pro‑inflammatory cytokine levels, and neuronal damage ( p < 0.05). Molecular analysis showed that SFN reduced the expression of TLR4, MyD88, p‐NF‐κB, NLRP3, and caspase‐1 ( p < 0.05). SFN combined with TAK‐242 did not further enhance the reduction of these indicators, compared with SFN alone. The TLR4/NF‐κB/NLRP3 signaling pathway plays a crucial role in SFN‐mediated attenuation of neuroinflammation and contributes to its antiepileptic and neuroprotective effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ningxia Key Laboratory of Craniocerebral Diseases, Ningxia Medical University, Yinchuan, China.
- School of Public Health, Ningxia Medical University, Ningxia Medical University, Yinchuan, China.
- Ningxia Key Laboratory of Environmental Factors and Chronic Disease Control, Yinchuan, China.
- Medical Records Department, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Clinical Nutrition, General Hospital of Ningxia Medical University, Yinchuan, China.
Förderung
- Natural Science Foundation of Ningxia
- Natural Science Foundation of Ningxia Province
Zitieren
APA
Zhou, G., Jin, J., Wang, J., Jia, X., Li, F., Guo, Y., Gong, Y., Zhang, K., Gao, C., Wang, W., & Zhang, R. (2026). Targeting TLR4‐Depended NLRP3 Inflammasome: Sulforaphane's Mechanism in Suppressing Neuroinflammation and Seizures in Epileptic Mice. Molecular Nutrition & Food Research, 70(11). https://doi.org/10.1002/mnfr.70510
Vancouver
Zhou G, Jin J, Wang J, Jia X, Li F, Guo Y, et al. Targeting TLR4‐Depended NLRP3 Inflammasome: Sulforaphane's Mechanism in Suppressing Neuroinflammation and Seizures in Epileptic Mice. Molecular Nutrition & Food Research. 2026;70(11). doi:10.1002/mnfr.70510
BibTeX
@article{Zhou2026,
author = {Zhou, Guoli and Jin, Jing and Wang, Jingwen and Jia, Xiandong and Li, Feihan and Guo, Yan and Gong, Yanan and Zhang, Kexin and Gao, Caibin and Wang, Weihong and Zhang, Rui},
title = {Targeting TLR4‐Depended NLRP3 Inflammasome: Sulforaphane's Mechanism in Suppressing Neuroinflammation and Seizures in Epileptic Mice},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {11},
doi = {10.1002/mnfr.70510}
}
EUVIMED